Elisabetta Petracci

2.0k total citations
62 papers, 1.1k citations indexed

About

Elisabetta Petracci is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Elisabetta Petracci has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 18 papers in Cancer Research and 15 papers in Molecular Biology. Recurrent topics in Elisabetta Petracci's work include Cancer Genomics and Diagnostics (11 papers), Lung Cancer Treatments and Mutations (10 papers) and Colorectal Cancer Treatments and Studies (6 papers). Elisabetta Petracci is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Lung Cancer Treatments and Mutations (10 papers) and Colorectal Cancer Treatments and Studies (6 papers). Elisabetta Petracci collaborates with scholars based in Italy, United States and Germany. Elisabetta Petracci's co-authors include Paola Ulivi, Lucio Crinò, Angelo Delmonte, Matteo Canale, Daniele Calistri, Rita Chiari, Vienna Ludovini, Dino Amadori, Elisa Chiadini and Giulia Cavrini and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

Elisabetta Petracci

56 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisabetta Petracci Italy	17	480	365	282	274	144	62	1.1k
Richard de Boer Australia	15	1.2k 2.5×	321 0.9×	333 1.2×	159 0.6×	186 1.3×	42	1.5k
Éric Voog France	19	900 1.9×	421 1.2×	243 0.9×	152 0.6×	222 1.5×	67	1.4k
Özlem Er Türkiye	15	594 1.2×	312 0.9×	241 0.9×	161 0.6×	156 1.1×	80	1.5k
Samuel S. Dychter United States	14	544 1.1×	268 0.7×	256 0.9×	114 0.4×	127 0.9×	25	1.2k
Giuseppe Maria Milano Italy	22	348 0.7×	519 1.4×	349 1.2×	141 0.5×	250 1.7×	100	1.6k
Mustafa Erman Türkiye	18	401 0.8×	271 0.7×	124 0.4×	84 0.3×	94 0.7×	117	1.0k
Maurizio Cantore Italy	23	812 1.7×	371 1.0×	198 0.7×	181 0.7×	357 2.5×	93	1.3k
Simona Secondino Italy	18	687 1.4×	227 0.6×	206 0.7×	84 0.3×	168 1.2×	59	1.2k
Maureen Reiner United States	22	707 1.5×	254 0.7×	129 0.5×	144 0.5×	218 1.5×	51	1.4k
Tim Harris United Kingdom	15	308 0.6×	88 0.2×	290 1.0×	462 1.7×	115 0.8×	30	1.2k

Countries citing papers authored by Elisabetta Petracci

Since Specialization

Citations

This map shows the geographic impact of Elisabetta Petracci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Petracci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Petracci more than expected).

Fields of papers citing papers by Elisabetta Petracci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Petracci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Petracci. The network helps show where Elisabetta Petracci may publish in the future.

Co-authorship network of co-authors of Elisabetta Petracci

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Petracci. A scholar is included among the top collaborators of Elisabetta Petracci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Petracci. Elisabetta Petracci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Canale, Matteo, Eugenio Fonzi, Letizia Gnetti, et al.. (2025). Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma Patients. PubMed. Volume 16. 85–96. 1 indexed citations

Pirini, Francesca, Luciano Calzari, Gianluca Tedaldi, et al.. (2025). Comprehensive genetic and epigenetic characterization of Lynch‐like syndrome patients. International Journal of Cancer. 157(4). 788–799.

Urbini, Milena, Chiara Casadei, Sabrina Rossetti, et al.. (2025). Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trial. ESMO Open. 10(5). 105056–105056.

Petracci, Elisabetta, Alessandro Passardi, Annibale Biggeri, et al.. (2024). Baseline and Longitudinal Neutrophil-to-Lymphocyte Ratio as Prognostic Factor for Metastatic Colorectal Cancer: A Secondary Analysis of the ITACa Randomized Trial. JCO Precision Oncology. 8(8). e2300256–e2300256. 1 indexed citations

Cortesi, Michela, Sara Bravaccini, Sara Ravaioli, et al.. (2024). HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer. Cancers. 16(22). 3752–3752.

Matteucci, Laura, Ilario Giovanni Rapposelli, Daniele Calistri, et al.. (2024). Multigene Panel Next-Generation Sequencing Techniques in the Management of Patients with Metastatic Colorectal Carcinoma: The Way Forward for Personalized Treatment? A Single-Center Experience. International Journal of Molecular Sciences. 25(20). 11071–11071. 2 indexed citations

Molinari, Chiara, Leonardo Solaini, Gianluca Tedaldi, et al.. (2024). Genomic events stratifying prognosis of early gastric cancer. Gastric Cancer. 27(6). 1189–1200.

Bertolini, Federica, Elisabetta Petracci, Stefania Bettelli, et al.. (2023). Genomic profiling in advanced NSCLC in Italy: First results of NERoNE (NSCLC Emilia Romagna Next Generation Sequencing Evaluation) project.. Journal of Clinical Oncology. 41(16_suppl). e21077–e21077.

Farolfi, Alberto, Elisabetta Petracci, Giorgia Gurioli, et al.. (2023). Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients. Frontiers in Oncology. 13. 2 indexed citations

10.

Nanni, Oriana, et al.. (2022). Fall predictors in hospitalized patients living with cancer: a case–control study. Supportive Care in Cancer. 30(10). 7835–7843. 3 indexed citations

11.

Passardi, Alessandro, Patrizia Serra, Orazio Caffo, et al.. (2022). Use of the ONCO-TreC electronic diary compared with a standard paper diary to improve adherence to oral cancer therapy in patients with solid and haematological tumours: protocol for a randomised controlled trial. BMJ Open. 12(1). e055814–e055814. 1 indexed citations

12.

Zingaretti, Chiara, Giorgio Papiani, Sara Pini, et al.. (2022). A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study final results.. Journal of Clinical Oncology. 40(17_suppl). LBA3513–LBA3513. 16 indexed citations

13.

Turroni, Silvia, Elisabetta Petracci, Valeria Edefonti, et al.. (2021). Effects of a Diet Based on Foods from Symbiotic Agriculture on the Gut Microbiota of Subjects at Risk for Metabolic Syndrome. Nutrients. 13(6). 2081–2081. 6 indexed citations

14.

Fontana, Maria Chiara, Jacopo Nanni, Andrea Ghelli Luserna di Rorà, et al.. (2021). Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a. Biomedicines. 9(4). 388–388. 9 indexed citations

15.

Solimando, Antonio Giovanni, Nicola Susca, Antonella Argentiero, et al.. (2021). Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis. Clinical and Experimental Medicine. 22(1). 65–74. 50 indexed citations

16.

Giudici, Fabiola, Elisabetta Petracci, Oriana Nanni, et al.. (2019). Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis. PLoS ONE. 14(6). e0218030–e0218030. 16 indexed citations

17.

Casadei‐Gardini, Andrea, Francesco Giuseppe Foschi, Fabio Conti, et al.. (2018). Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals. Digestive and Liver Disease. 51(5). 681–688. 47 indexed citations

18.

Conti, Fabio, Elisabetta Petracci, Giorgia Marisi, et al.. (2018). Immune inflammation indicators and ALBI score to predict occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. Digestive and Liver Disease. 50(1). 50–51. 2 indexed citations

19.

Canale, Matteo, Elisabetta Petracci, Angelo Delmonte, et al.. (2016). Impact of TP53 Mutations on Outcome in EGFR -Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors. Clinical Cancer Research. 23(9). 2195–2202. 196 indexed citations

20.

Zucchelli, Giovanni, Ilham Mounssif, Claudio Mazzotti, et al.. (2013). Coronally advanced flap with and without connective tissue graft for the treatment of multiple gingival recessions: a comparative short‐ and long‐term controlled randomized clinical trial. Journal Of Clinical Periodontology. 41(4). 396–403. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact